Prescribing Practices Amid the OxyContin Crisis: Examining the Effect of Print Media Coverage on Opioid Prescribing Among Physicians
Abstract The pain medication OxyContin (hereafter referred to as oxycodone extended release) has been the subject of sustained, and largely negative, media attention in recent years. We sought to determine whether media coverage of oxycodone extended release in North American newspapers has led to c...
Saved in:
| Published in | The journal of pain Vol. 14; no. 12; pp. 1686 - 1693.e1 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.12.2013
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1526-5900 1528-8447 1528-8447 |
| DOI | 10.1016/j.jpain.2013.08.012 |
Cover
Loading…
| Abstract | Abstract The pain medication OxyContin (hereafter referred to as oxycodone extended release) has been the subject of sustained, and largely negative, media attention in recent years. We sought to determine whether media coverage of oxycodone extended release in North American newspapers has led to changes in prescribing of the drug in Nova Scotia, Canada. An interrupted time-series design examined the effect of media attention on physicians' monthly prescribing of opioids. The outcome measures were, for each physician, the monthly proportions of all opioids prescribed and the proportion of strong opioids prescribed that were for oxycodone extended release. The exposure of interest was media attention defined as the number of articles published each month in 27 North American newspapers. Variations in media effects by provider characteristics (specialty, prescribing volume, and region) were assessed. Within-provider changes in the prescribing of oxycodone extended release in Nova Scotia were observed, and they followed changes in media coverage. Oxycodone extended release prescribing rose steadily prior to receiving media attention. Following peak media attention in the United States, the prescribing of oxycodone extended release slowed. Likewise, following peak coverage in Canadian newspapers, the prescribing of oxycodone extended release declined. These patterns were observed across prescriber specialties and by prescriber volume, though the magnitude of change in prescribing varied. Perspective This study demonstrates that print media reporting of oxycodone extended release in North American newspapers, and its continued portrayal as a social problem, coincided with reductions in the prescribing of oxycodone extended release by physicians in Nova Scotia. |
|---|---|
| AbstractList | The pain medication OxyContin (hereafter referred to as oxycodone extended release) has been the subject of sustained, and largely negative, media attention in recent years. We sought to determine whether media coverage of oxycodone extended release in North American newspapers has led to changes in prescribing of the drug in Nova Scotia, Canada. An interrupted time-series design examined the effect of media attention on physicians' monthly prescribing of opioids. The outcome measures were, for each physician, the monthly proportions of all opioids prescribed and the proportion of strong opioids prescribed that were for oxycodone extended release. The exposure of interest was media attention defined as the number of articles published each month in 27 North American newspapers. Variations in media effects by provider characteristics (specialty, prescribing volume, and region) were assessed. Within-provider changes in the prescribing of oxycodone extended release in Nova Scotia were observed, and they followed changes in media coverage. Oxycodone extended release prescribing rose steadily prior to receiving media attention. Following peak media attention in the United States, the prescribing of oxycodone extended release slowed. Likewise, following peak coverage in Canadian newspapers, the prescribing of oxycodone extended release declined. These patterns were observed across prescriber specialties and by prescriber volume, though the magnitude of change in prescribing varied.
This study demonstrates that print media reporting of oxycodone extended release in North American newspapers, and its continued portrayal as a social problem, coincided with reductions in the prescribing of oxycodone extended release by physicians in Nova Scotia. The pain medication OxyContin (hereafter referred to as oxycodone extended release) has been the subject of sustained, and largely negative, media attention in recent years. We sought to determine whether media coverage of oxycodone extended release in North American newspapers has led to changes in prescribing of the drug in Nova Scotia, Canada. An interrupted time-series design examined the effect of media attention on physicians' monthly prescribing of opioids. The outcome measures were, for each physician, the monthly proportions of all opioids prescribed and the proportion of strong opioids prescribed that were for oxycodone extended release. The exposure of interest was media attention defined as the number of articles published each month in 27 North American newspapers. Variations in media effects by provider characteristics (specialty, prescribing volume, and region) were assessed. Within-provider changes in the prescribing of oxycodone extended release in Nova Scotia were observed, and they followed changes in media coverage. Oxycodone extended release prescribing rose steadily prior to receiving media attention. Following peak media attention in the United States, the prescribing of oxycodone extended release slowed. Likewise, following peak coverage in Canadian newspapers, the prescribing of oxycodone extended release declined. These patterns were observed across prescriber specialties and by prescriber volume, though the magnitude of change in prescribing varied.UNLABELLEDThe pain medication OxyContin (hereafter referred to as oxycodone extended release) has been the subject of sustained, and largely negative, media attention in recent years. We sought to determine whether media coverage of oxycodone extended release in North American newspapers has led to changes in prescribing of the drug in Nova Scotia, Canada. An interrupted time-series design examined the effect of media attention on physicians' monthly prescribing of opioids. The outcome measures were, for each physician, the monthly proportions of all opioids prescribed and the proportion of strong opioids prescribed that were for oxycodone extended release. The exposure of interest was media attention defined as the number of articles published each month in 27 North American newspapers. Variations in media effects by provider characteristics (specialty, prescribing volume, and region) were assessed. Within-provider changes in the prescribing of oxycodone extended release in Nova Scotia were observed, and they followed changes in media coverage. Oxycodone extended release prescribing rose steadily prior to receiving media attention. Following peak media attention in the United States, the prescribing of oxycodone extended release slowed. Likewise, following peak coverage in Canadian newspapers, the prescribing of oxycodone extended release declined. These patterns were observed across prescriber specialties and by prescriber volume, though the magnitude of change in prescribing varied.This study demonstrates that print media reporting of oxycodone extended release in North American newspapers, and its continued portrayal as a social problem, coincided with reductions in the prescribing of oxycodone extended release by physicians in Nova Scotia.PERSPECTIVEThis study demonstrates that print media reporting of oxycodone extended release in North American newspapers, and its continued portrayal as a social problem, coincided with reductions in the prescribing of oxycodone extended release by physicians in Nova Scotia. Abstract The pain medication OxyContin (hereafter referred to as oxycodone extended release) has been the subject of sustained, and largely negative, media attention in recent years. We sought to determine whether media coverage of oxycodone extended release in North American newspapers has led to changes in prescribing of the drug in Nova Scotia, Canada. An interrupted time-series design examined the effect of media attention on physicians' monthly prescribing of opioids. The outcome measures were, for each physician, the monthly proportions of all opioids prescribed and the proportion of strong opioids prescribed that were for oxycodone extended release. The exposure of interest was media attention defined as the number of articles published each month in 27 North American newspapers. Variations in media effects by provider characteristics (specialty, prescribing volume, and region) were assessed. Within-provider changes in the prescribing of oxycodone extended release in Nova Scotia were observed, and they followed changes in media coverage. Oxycodone extended release prescribing rose steadily prior to receiving media attention. Following peak media attention in the United States, the prescribing of oxycodone extended release slowed. Likewise, following peak coverage in Canadian newspapers, the prescribing of oxycodone extended release declined. These patterns were observed across prescriber specialties and by prescriber volume, though the magnitude of change in prescribing varied. Perspective This study demonstrates that print media reporting of oxycodone extended release in North American newspapers, and its continued portrayal as a social problem, coincided with reductions in the prescribing of oxycodone extended release by physicians in Nova Scotia. |
| Author | Whelan, Emma Asbridge, Mark Borwein, Alexandra Kephart, George |
| Author_xml | – sequence: 1 fullname: Borwein, Alexandra – sequence: 2 fullname: Kephart, George – sequence: 3 fullname: Whelan, Emma – sequence: 4 fullname: Asbridge, Mark |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24290448$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkktr3DAUhU1JaB7tLygULbuxq5fHcqGFYZg-IGUCbddClq-T69rSVPKEzD4_vHImgZBFu9IFne9cOOeeZUfOO8iyN4wWjLLF-77otwZdwSkTBVUFZfxFdspKrnIlZXV0Py_ysqb0JDuLsaeUsbKqXmYnXPKaSqlOs7vLANEGbNBdkctg7IQWIlmO2JLpGsjmdr_ybkJHVgEjxg9kfWtGdLN8_l93HdiJ-C7B6CbyHVo0ZOVvIJgrIN6RzRZ9Mnu6Zzn6edv1PqJF4-Kr7LgzQ4TXD-959uvz-ufqa36x-fJttbzIrWRyyssKeMeEksAa05aVoqpWqrJV1Yi2aYQQJRW15E3biEpYLlVjSi5b20Jd19KK8-zdwXcb_J8dxEmPGC0Mg3Hgd1EzuZCylpTWSfr2QbprRmj1NuBowl4_JpcE9UFgg48xQKctTmbCFFYwOGhG9dyS7vV9S3puSVOlU0uJFc_YR_t_Ux8PFKSIbhCCjhbB2ZR4SB3o1uN_-E_PeDukIq0ZfsMeYu93waX0NdORa6p_zNczHw8TM81K8Rf-qMGa |
| CitedBy_id | crossref_primary_10_1016_j_drugalcdep_2019_107599 crossref_primary_10_1016_j_jss_2020_07_009 crossref_primary_10_1007_s10029_022_02661_3 crossref_primary_10_1007_s12024_014_9624_x crossref_primary_10_1080_01639625_2019_1607114 crossref_primary_10_1007_s10912_024_09918_1 crossref_primary_10_1093_pm_pnz104 crossref_primary_10_1093_pm_pnaa412 crossref_primary_10_1016_j_jpain_2019_04_007 crossref_primary_10_1371_journal_pone_0173202 crossref_primary_10_1186_s13011_021_00396_5 crossref_primary_10_1093_pm_pnaa045 crossref_primary_10_2196_17693 crossref_primary_10_1186_s12913_019_4642_8 crossref_primary_10_1136_bmjopen_2023_074423 crossref_primary_10_1136_bmjqs_2018_007840 crossref_primary_10_1186_s40545_022_00423_1 crossref_primary_10_1016_j_jss_2019_03_043 |
| Cites_doi | 10.1016/0002-9343(82)90911-1 10.1155/2006/753083 10.1371/journal.pmed.1000352 10.1016/j.jpain.2009.03.019 10.1002/pds.2259 10.1001/jama.291.1.47 10.7326/0003-4819-140-3-200402030-00009 10.1086/321856 10.1016/j.jpain.2005.05.004 10.1155/2011/867326 10.1016/S0140-6736(97)11390-3 10.1136/bmj.327.7419.845 10.1111/j.1365-2125.2005.02502.x 10.1111/j.1755-5922.2009.00083.x 10.1111/j.1464-5491.2008.02462.x |
| ContentType | Journal Article |
| Copyright | American Pain Society 2013 American Pain Society Copyright © 2013 American Pain Society. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: American Pain Society – notice: 2013 American Pain Society – notice: Copyright © 2013 American Pain Society. Published by Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.jpain.2013.08.012 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1528-8447 |
| EndPage | 1693.e1 |
| ExternalDocumentID | 24290448 10_1016_j_jpain_2013_08_012 S1526590013012315 1_s2_0_S1526590013012315 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | North America |
| GeographicLocations_xml | – name: North America |
| GrantInformation_xml | – fundername: Canadian Institutes for Health Research master's award – fundername: Nova Scotia Health Research Foundation |
| GroupedDBID | --- --K --M .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAWTL AAXLA AAXUO ABBQC ABCQJ ABIVO ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACJTP ACRPL ADBBV ADEZE ADMUD ADNMO ADVLN AEKER AENEX AEVXI AFJKZ AFTJW AFXBA AGHFR AGUBO AGWIK AGYEJ AITUG AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AZFZN BLXMC CAG COF CS3 DU5 EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU G-Q GBLVA HVGLF HZ~ IHE J1W J5H K-O L7B M41 MO0 MOBAO N9A O-L O9- OAUVE OG. OS- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SEL SES SEW SSZ T5K UHS UNMZH UV1 ~G- AAYWO AAYXX ACVFH ADCNI AEUPX AFPUW AGCQF AGQPQ AIGII AKBMS AKYEP APXCP CITATION CGR CUY CVF ECM EFKBS EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c414t-57e2f1384e1bad578089887c77b3dbb333503942bdb373c248ba524dcde9994c3 |
| IEDL.DBID | .~1 |
| ISSN | 1526-5900 1528-8447 |
| IngestDate | Fri Jul 11 04:01:36 EDT 2025 Mon Jul 21 05:55:54 EDT 2025 Tue Jul 01 01:15:45 EDT 2025 Thu Apr 24 23:02:16 EDT 2025 Sun Apr 06 06:53:47 EDT 2025 Sun Feb 23 10:18:42 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | OxyContin prescribing practices Opioids media effects |
| Language | English |
| License | Copyright © 2013 American Pain Society. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c414t-57e2f1384e1bad578089887c77b3dbb333503942bdb373c248ba524dcde9994c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 24290448 |
| PQID | 1464494009 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1464494009 pubmed_primary_24290448 crossref_citationtrail_10_1016_j_jpain_2013_08_012 crossref_primary_10_1016_j_jpain_2013_08_012 elsevier_sciencedirect_doi_10_1016_j_jpain_2013_08_012 elsevier_clinicalkeyesjournals_1_s2_0_S1526590013012315 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2013-12-01 |
| PublicationDateYYYYMMDD | 2013-12-01 |
| PublicationDate_xml | – month: 12 year: 2013 text: 2013-12-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The journal of pain |
| PublicationTitleAlternate | J Pain |
| PublicationYear | 2013 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | George, Hannah, Lang (bib10) 2009; 27 Lawton, Rose, McLeod, Dowell (bib13) 2003; 327 National Opioid Use Guideline Group (NOUGG): Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. 2010. Available at Cicero, Inciardi, Munoz (bib4) 2005; 6 (bib20) 2011 Hersch, Stefanick, Stafford (bib12) 2004; 291 Accessed May 10, 2007 Accessed August 19, 2004 Nova Scotia Prescription Monitoring Program: Nova Scotia Prescription Monitoring Program annual report: 2010-2011. 2011. Available at Spurling, Mansfield, Montgomery, Lexchin, Doust, Othman, Vitry (bib24) 2010; 7 Borenstein, Hedges, Higgins, Rothstein (bib2) 2009 Dhalla, Mamdani, Gomes, Juurlink (bib5) 2011; 57 Meier B: In guilty plea, OxyContin maker to pay $600 million. New York Times. Available at WHO ATC/DDD index 2012. Oslo, Norway, WHO Collaborating Centre for Drug Statistics Methodology. 2011. Available at Neter, Wasserman (bib18) 1974 National Post: Canada won't block generic OxyContin: Health minister. November 19, 2012 Victor, Alvarez, Gould (bib26) 2009; 10 Whelan, Asbridge, Haydt (bib27) 2011; 16 The Chronicle Herald. Doctor's suspension worries groups. May 3, 2006 Shah, Juurlink, Austin, Mamdani (bib22) 2008; 25 Accessed December 2, 2012 Fisher, Zhang, Sketris, Johnston, Burge (bib8) 2012; 21 Canadian Pain Society: Media coverage of OxyContin is one-sided: A statement from the Canadian Pain Society [press release]. Available at Fact Sheet: Misuse and abuse of oxycodone-based prescription drugs [Internet]. Health Canada. Available at Avorn, Chen, Hartley (bib1) 1982; 73 Sbarbaro (bib21) 2001; 33 Haas, Kaplan, Gerstenberger, Kerlikowske (bib11) 2004; 140 WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment 2012. 15th ed. Oslo, Norway. 2011. Available at FitzGerald, Boulet, McIvor, Zimmerman, Chapman (bib9) 2006; 13 Sketris, Langille Ingram, Lummis (bib23) 2009; 16 Faber, Bouvy, Loskamp, van de Berg, Egberts, de Jong-van den Berg (bib6) 2005; 60 Maclure, Dormuth, Naumann, McCormack, Rangno, Whiteside, Wright (bib14) 1998; 352 Maclure (10.1016/j.jpain.2013.08.012_bib14) 1998; 352 10.1016/j.jpain.2013.08.012_bib25 Cicero (10.1016/j.jpain.2013.08.012_bib4) 2005; 6 Lawton (10.1016/j.jpain.2013.08.012_bib13) 2003; 327 10.1016/j.jpain.2013.08.012_bib29 10.1016/j.jpain.2013.08.012_bib28 George (10.1016/j.jpain.2013.08.012_bib10) 2009; 27 Fisher (10.1016/j.jpain.2013.08.012_bib8) 2012; 21 10.1016/j.jpain.2013.08.012_bib7 Hersch (10.1016/j.jpain.2013.08.012_bib12) 2004; 291 Sketris (10.1016/j.jpain.2013.08.012_bib23) 2009; 16 10.1016/j.jpain.2013.08.012_bib3 Haas (10.1016/j.jpain.2013.08.012_bib11) 2004; 140 Faber (10.1016/j.jpain.2013.08.012_bib6) 2005; 60 10.1016/j.jpain.2013.08.012_bib15 Avorn (10.1016/j.jpain.2013.08.012_bib1) 1982; 73 10.1016/j.jpain.2013.08.012_bib19 10.1016/j.jpain.2013.08.012_bib17 10.1016/j.jpain.2013.08.012_bib16 (10.1016/j.jpain.2013.08.012_bib20) 2011 Sbarbaro (10.1016/j.jpain.2013.08.012_bib21) 2001; 33 Dhalla (10.1016/j.jpain.2013.08.012_bib5) 2011; 57 FitzGerald (10.1016/j.jpain.2013.08.012_bib9) 2006; 13 Spurling (10.1016/j.jpain.2013.08.012_bib24) 2010; 7 Shah (10.1016/j.jpain.2013.08.012_bib22) 2008; 25 Borenstein (10.1016/j.jpain.2013.08.012_bib2) 2009 Victor (10.1016/j.jpain.2013.08.012_bib26) 2009; 10 Whelan (10.1016/j.jpain.2013.08.012_bib27) 2011; 16 Neter (10.1016/j.jpain.2013.08.012_bib18) 1974 |
| References_xml | – volume: 6 start-page: 662 year: 2005 end-page: 667 ident: bib4 article-title: Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002-2004 publication-title: J Pain – reference: . Accessed August 19, 2004 – reference: . Accessed December 2, 2012 – year: 2011 ident: bib20 article-title: Product Monograph: OxyNeo – volume: 16 start-page: e103 year: 2009 end-page: e125 ident: bib23 article-title: Strategic opportunities for effective optimal prescribing and medication management publication-title: Can J Clin Pharmacol – volume: 7 start-page: e1000352 year: 2010 ident: bib24 article-title: Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: A systematic review publication-title: PLoS Med – reference: The Chronicle Herald. Doctor's suspension worries groups. May 3, 2006 – volume: 33 start-page: S240 year: 2001 end-page: S244 ident: bib21 article-title: Can we influence prescribing patterns? publication-title: Clin Infect Dis – volume: 16 start-page: 252 year: 2011 end-page: 258 ident: bib27 article-title: Representations of OxyContin in North American newspapers and medical journals publication-title: Pain Res Manag – reference: WHO ATC/DDD index 2012. Oslo, Norway, WHO Collaborating Centre for Drug Statistics Methodology. 2011. Available at: – reference: Meier B: In guilty plea, OxyContin maker to pay $600 million. New York Times. Available at: – reference: Fact Sheet: Misuse and abuse of oxycodone-based prescription drugs [Internet]. Health Canada. Available at: – reference: National Post: Canada won't block generic OxyContin: Health minister. November 19, 2012 – volume: 27 start-page: 83 year: 2009 end-page: 88 ident: bib10 article-title: Thiazolidinediones and the influence of media adverse reporting on prescribing attitudes in practice (TZD-IMPACT) study publication-title: Cardiovasc Ther – volume: 25 start-page: 871 year: 2008 end-page: 874 ident: bib22 article-title: New use of rosiglitazone decreased following publication of a meta-analysis suggesting harm publication-title: Diabet Med – volume: 291 start-page: 47 year: 2004 end-page: 53 ident: bib12 article-title: National use of postmenopausal hormone therapy: National trends and response to recent evidence publication-title: J Am Med Assoc – reference: Nova Scotia Prescription Monitoring Program: Nova Scotia Prescription Monitoring Program annual report: 2010-2011. 2011. Available at: – reference: National Opioid Use Guideline Group (NOUGG): Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. 2010. Available at: – reference: WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment 2012. 15th ed. Oslo, Norway. 2011. Available at: – volume: 21 start-page: 177 year: 2012 end-page: 183 ident: bib8 article-title: The effect of an educational intervention on meperidine use in Nova Scotia, Canada: A time series analysis publication-title: Pharmacoepidemiol Drug Saf – volume: 60 start-page: 641 year: 2005 end-page: 647 ident: bib6 article-title: Dramatic change in prescribing of hormone replacement therapy in the Netherlands after publication of the million Women Study: A follow-up study publication-title: Br J Clin Pharmacol – volume: 352 start-page: 943 year: 1998 end-page: 948 ident: bib14 article-title: Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia publication-title: Lancet – volume: 13 start-page: 253 year: 2006 end-page: 259 ident: bib9 article-title: Asthma control in Canada remains suboptimal: The Reality of Asthma Control (TRAC) study publication-title: Can Respir J – reference: Canadian Pain Society: Media coverage of OxyContin is one-sided: A statement from the Canadian Pain Society [press release]. Available at: – volume: 10 start-page: 1051 year: 2009 end-page: 1057 ident: bib26 article-title: Opioid prescribing practices in chronic pain management: Guidelines do not sufficiently influence clinical practice publication-title: J Pain – volume: 57 start-page: e92 year: 2011 end-page: e96 ident: bib5 article-title: Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario publication-title: Can Fam Physician – volume: 327 start-page: 845 year: 2003 end-page: 846 ident: bib13 article-title: Changes in the use of hormone replacement therapy after the report from the Women's Health Initiative: Cross sectional survey of users publication-title: BMJ – volume: 73 start-page: 4 year: 1982 end-page: 8 ident: bib1 article-title: Scientific versus commercial sources of influence on the prescribing behavior of physicians publication-title: Am J Med – year: 2009 ident: bib2 article-title: Introduction to Meta-analysis – reference: . Accessed May 10, 2007 – volume: 140 start-page: 184 year: 2004 end-page: 188 ident: bib11 article-title: Changes in the use of postmenopausal hormone replacement therapy after the publication of clinical trial results publication-title: Ann Intern Med – year: 1974 ident: bib18 article-title: Applied Linear Statistical Models; Regression, Analysis of Variance, and Experimental Designs – ident: 10.1016/j.jpain.2013.08.012_bib16 – year: 2009 ident: 10.1016/j.jpain.2013.08.012_bib2 – volume: 73 start-page: 4 year: 1982 ident: 10.1016/j.jpain.2013.08.012_bib1 article-title: Scientific versus commercial sources of influence on the prescribing behavior of physicians publication-title: Am J Med doi: 10.1016/0002-9343(82)90911-1 – volume: 13 start-page: 253 year: 2006 ident: 10.1016/j.jpain.2013.08.012_bib9 article-title: Asthma control in Canada remains suboptimal: The Reality of Asthma Control (TRAC) study publication-title: Can Respir J doi: 10.1155/2006/753083 – volume: 7 start-page: e1000352 year: 2010 ident: 10.1016/j.jpain.2013.08.012_bib24 article-title: Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: A systematic review publication-title: PLoS Med doi: 10.1371/journal.pmed.1000352 – volume: 10 start-page: 1051 year: 2009 ident: 10.1016/j.jpain.2013.08.012_bib26 article-title: Opioid prescribing practices in chronic pain management: Guidelines do not sufficiently influence clinical practice publication-title: J Pain doi: 10.1016/j.jpain.2009.03.019 – volume: 21 start-page: 177 year: 2012 ident: 10.1016/j.jpain.2013.08.012_bib8 article-title: The effect of an educational intervention on meperidine use in Nova Scotia, Canada: A time series analysis publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.2259 – volume: 291 start-page: 47 year: 2004 ident: 10.1016/j.jpain.2013.08.012_bib12 article-title: National use of postmenopausal hormone therapy: National trends and response to recent evidence publication-title: J Am Med Assoc doi: 10.1001/jama.291.1.47 – volume: 140 start-page: 184 year: 2004 ident: 10.1016/j.jpain.2013.08.012_bib11 article-title: Changes in the use of postmenopausal hormone replacement therapy after the publication of clinical trial results publication-title: Ann Intern Med doi: 10.7326/0003-4819-140-3-200402030-00009 – volume: 33 start-page: S240 year: 2001 ident: 10.1016/j.jpain.2013.08.012_bib21 article-title: Can we influence prescribing patterns? publication-title: Clin Infect Dis doi: 10.1086/321856 – volume: 6 start-page: 662 year: 2005 ident: 10.1016/j.jpain.2013.08.012_bib4 article-title: Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002-2004 publication-title: J Pain doi: 10.1016/j.jpain.2005.05.004 – volume: 16 start-page: 252 year: 2011 ident: 10.1016/j.jpain.2013.08.012_bib27 article-title: Representations of OxyContin in North American newspapers and medical journals publication-title: Pain Res Manag doi: 10.1155/2011/867326 – ident: 10.1016/j.jpain.2013.08.012_bib28 – volume: 352 start-page: 943 year: 1998 ident: 10.1016/j.jpain.2013.08.012_bib14 article-title: Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia publication-title: Lancet doi: 10.1016/S0140-6736(97)11390-3 – ident: 10.1016/j.jpain.2013.08.012_bib3 – volume: 327 start-page: 845 year: 2003 ident: 10.1016/j.jpain.2013.08.012_bib13 article-title: Changes in the use of hormone replacement therapy after the report from the Women's Health Initiative: Cross sectional survey of users publication-title: BMJ doi: 10.1136/bmj.327.7419.845 – ident: 10.1016/j.jpain.2013.08.012_bib17 – year: 2011 ident: 10.1016/j.jpain.2013.08.012_bib20 – ident: 10.1016/j.jpain.2013.08.012_bib15 – volume: 60 start-page: 641 year: 2005 ident: 10.1016/j.jpain.2013.08.012_bib6 article-title: Dramatic change in prescribing of hormone replacement therapy in the Netherlands after publication of the million Women Study: A follow-up study publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2005.02502.x – volume: 16 start-page: e103 year: 2009 ident: 10.1016/j.jpain.2013.08.012_bib23 article-title: Strategic opportunities for effective optimal prescribing and medication management publication-title: Can J Clin Pharmacol – ident: 10.1016/j.jpain.2013.08.012_bib7 – volume: 27 start-page: 83 year: 2009 ident: 10.1016/j.jpain.2013.08.012_bib10 article-title: Thiazolidinediones and the influence of media adverse reporting on prescribing attitudes in practice (TZD-IMPACT) study publication-title: Cardiovasc Ther doi: 10.1111/j.1755-5922.2009.00083.x – ident: 10.1016/j.jpain.2013.08.012_bib19 – volume: 25 start-page: 871 year: 2008 ident: 10.1016/j.jpain.2013.08.012_bib22 article-title: New use of rosiglitazone decreased following publication of a meta-analysis suggesting harm publication-title: Diabet Med doi: 10.1111/j.1464-5491.2008.02462.x – volume: 57 start-page: e92 year: 2011 ident: 10.1016/j.jpain.2013.08.012_bib5 article-title: Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario publication-title: Can Fam Physician – year: 1974 ident: 10.1016/j.jpain.2013.08.012_bib18 – ident: 10.1016/j.jpain.2013.08.012_bib25 – ident: 10.1016/j.jpain.2013.08.012_bib29 |
| SSID | ssj0011577 |
| Score | 2.1783488 |
| Snippet | Abstract The pain medication OxyContin (hereafter referred to as oxycodone extended release) has been the subject of sustained, and largely negative, media... The pain medication OxyContin (hereafter referred to as oxycodone extended release) has been the subject of sustained, and largely negative, media attention in... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1686 |
| SubjectTerms | Adult Aged Analgesics, Opioid - therapeutic use Anesthesia & Perioperative Care Drug Prescriptions Female Humans Male Mass Media - trends media effects Middle Aged North America - epidemiology Opioids Oxycodone - therapeutic use OxyContin Pain Medicine Physicians - trends prescribing practices Time and Motion Studies |
| Title | Prescribing Practices Amid the OxyContin Crisis: Examining the Effect of Print Media Coverage on Opioid Prescribing Among Physicians |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1526590013012315 https://dx.doi.org/10.1016/j.jpain.2013.08.012 https://www.ncbi.nlm.nih.gov/pubmed/24290448 https://www.proquest.com/docview/1464494009 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhh5JLaZM-tm2KCj3WXb28Wue2LAkhkCaQBnITerk4NPZSbyC99NQfnhlZXlpKcujRtkayNZrRjDXzDSEfwQKtwSqoCxGjLBRnrLCyBK-10iyUs1rFlEh7-mV2fKlOrsqrLbIcc2EwrDLr_kGnJ22d70zzbE5XTTO94IjsXqWjN1C_KdFcKY34-Z9_bcI8EEsmFViBxgW2HpGHUozX9Qrcb4zvkgnHk4uHdqeHrM-0Cx09I0-z-UgXwxs-J1ux3SVPTvMB-R75jSEVoAjA3_1Gz3MGVE8XN02gYOrRs7ufiEfVtHQJ0t30B_Twzt6kIhHp-QBmTLsaiJt2TbFnS5cY5wmKh3YtPVs1HXT25zgLLFhEz8d_JP0Lcnl0-HV5XORCC4VXXK2LUkdRczlXkTsbQIbZvALl47V2MjgnpSyZrJRwwUktvVBzZ0uhgg8R7Evl5Uuy3XZtfE1oAM5br2dWOQTq5044y7ysgtaRKS8mRIwTbHxGIcdiGN_NGG52bRJXDHLFYIlMDkSfNkSrAYTj8eZ65JwZ80tBI8Y-i2dvuOmFYeafJTQhsw3lX6vQwAbz-JAfxhViQD7x0MW2sbvt0bVSCqvPVxPyalg6m28A86hi4B-_-d9h35IdvBrCa96R7fWP27gPRtLavU9ScA8bTQ3P |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgEXxJstLyNxJGz8yHrDbbVqtUC3rUQr9Wb5lSoVTVZkK7UXTvxwZhxnBULtgWvssRN7ZjwTz3xDyHuwQCuwCqqMhyAyyfI8M6IAr7VUuS8mlQwxkXZ5MFmcyC-nxekWmQ-5MBhWmXR_r9Ojtk5Pxmk1x6u6Hn9jiOxexqs3UL-YaH5HFkIha3_8uYnzQDCZWGEFemfYfYAeikFe5yvwvzHAS0QgT8ZvOp5uMj_jMbT3kDxI9iOd9a_4iGyF5jG5u0w35E_IL4ypAE0ADu8ZPUopUB2dXdSegq1HD6-uEZCqbugcxLvuPtHdK3MRq0TE9h7NmLYVENfNmuLIhs4x0BM0D20beriqWxjsz3lmWLGIHg0_Sbqn5GRv93i-yFKlhcxJJtdZoQKvmJjKwKzxIMT5tATt45SywlsrhChyUUpuvRVKOC6n1hRceucDGJjSiWdku2mb8IJQD1tvnJoYaRGpn1luTe5E6ZUKuXR8RPiwwNolGHKshvFdD_Fm5zruisZd0VgjkwHRhw3RqkfhuL27GnZODwmmoBJDl-Sz00x3XOf6Hx4akcmG8i821HDC3D7lu4FDNAgo3rqYJrSXHfpWUmL5-XJEnvess_kGsI_KHBzknf-d9i25tzhe7uv9zwdfX5L72NLH2rwi2-sfl-E1WExr-yZKxG-49BDz |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prescribing+Practices+Amid+the+OxyContin+Crisis%3A+Examining+the+Effect+of+Print+Media+Coverage+on+Opioid+Prescribing+Among+Physicians&rft.jtitle=The+journal+of+pain&rft.au=Borwein%2C+Alexandra&rft.au=Kephart%2C+George&rft.au=Whelan%2C+Emma&rft.au=Asbridge%2C+Mark&rft.date=2013-12-01&rft.issn=1526-5900&rft.volume=14&rft.issue=12&rft.spage=1686&rft.epage=1693.e1&rft_id=info:doi/10.1016%2Fj.jpain.2013.08.012&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jpain_2013_08_012 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15265900%2FS1526590013X00124%2Fcov150h.gif |